LANXESS AG (1LXS.MI) Stock Fundamental Analysis
Europe - BIT:1LXS - DE0005470405 - Common Stock
21.72 EUR
-4.86 (-18.28%)
Taking everything into account, 1LXS scores 3 out of 10 in our fundamental rating. 1LXS was compared to 71 industry peers in the Chemicals industry. 1LXS has a bad profitability rating. Also its financial health evaluation is rather negative. 1LXS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
1LXS had positive earnings in the past year.
1LXS had a positive operating cash flow in the past year.
Of the past 5 years 1LXS 4 years were profitable.
In the past 5 years 1LXS always reported a positive cash flow from operatings.
1.2 Ratios
1LXS has a Return On Assets of -1.43%. This is in the lower half of the industry: 1LXS underperforms 64.79% of its industry peers.
With a Return On Equity value of -3.12%, 1LXS is not doing good in the industry: 64.79% of the companies in the same industry are doing better.
1LXS has a worse Return On Invested Capital (0.06%) than 66.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.12% | ||
| ROIC | 0.06% |
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 0.09%, 1LXS is not doing good in the industry: 66.20% of the companies in the same industry are doing better.
1LXS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 21.07%, 1LXS is not doing good in the industry: 69.01% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of 1LXS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.09% | ||
| PM (TTM) | N/A | ||
| GM | 21.07% |
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
2. Health
2.1 Basic Checks
1LXS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 1LXS remains at a similar level compared to 1 year ago.
The number of shares outstanding for 1LXS has been increased compared to 5 years ago.
1LXS has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.76, we must say that 1LXS is in the distress zone and has some risk of bankruptcy.
1LXS has a Altman-Z score of 1.76. This is in the lower half of the industry: 1LXS underperforms 64.79% of its industry peers.
The Debt to FCF ratio of 1LXS is 28.05, which is on the high side as it means it would take 1LXS, 28.05 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1LXS (28.05) is comparable to the rest of the industry.
1LXS has a Debt/Equity ratio of 0.56. This is a neutral value indicating 1LXS is somewhat dependend on debt financing.
1LXS's Debt to Equity ratio of 0.56 is in line compared to the rest of the industry. 1LXS outperforms 45.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 28.05 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.01
WACC4.84%
2.3 Liquidity
A Current Ratio of 1.90 indicates that 1LXS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.90, 1LXS is doing good in the industry, outperforming 63.38% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that 1LXS should not have too much problems paying its short term obligations.
1LXS has a Quick ratio of 1.13. This is comparable to the rest of the industry: 1LXS outperforms 53.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 190.48% over the past year.
The earnings per share for 1LXS have been decreasing by -19.38% on average. This is quite bad
The Revenue has decreased by -0.97% in the past year.
1LXS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.32% yearly.
EPS 1Y (TTM)190.48%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%355.56%
Revenue 1Y (TTM)-0.97%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-0.37%
3.2 Future
Based on estimates for the next years, 1LXS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.72% on average per year.
Based on estimates for the next years, 1LXS will show a small growth in Revenue. The Revenue will grow by 1.76% on average per year.
EPS Next Y2.56%
EPS Next 2Y16.02%
EPS Next 3Y13.72%
EPS Next 5YN/A
Revenue Next Year-1.4%
Revenue Next 2Y0.81%
Revenue Next 3Y1.76%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1LXS is valuated reasonably with a Price/Earnings ratio of 11.43.
1LXS's Price/Earnings ratio is rather cheap when compared to the industry. 1LXS is cheaper than 88.73% of the companies in the same industry.
1LXS is valuated cheaply when we compare the Price/Earnings ratio to 27.90, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.21, which indicates a very decent valuation of 1LXS.
1LXS's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1LXS is cheaper than 90.14% of the companies in the same industry.
1LXS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.43 | ||
| Fwd PE | 10.21 |
4.2 Price Multiples
74.65% of the companies in the same industry are more expensive than 1LXS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, 1LXS is valued a bit cheaper than 76.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.53 | ||
| EV/EBITDA | 7.16 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1LXS's earnings are expected to grow with 13.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.47
PEG (5Y)N/A
EPS Next 2Y16.02%
EPS Next 3Y13.72%
5. Dividend
5.1 Amount
1LXS has a yearly dividend return of 0.39%, which is pretty low.
1LXS's Dividend Yield is slightly below the industry average, which is at 3.05.
With a Dividend Yield of 0.39, 1LXS pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of 1LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1LXS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.62%
EPS Next 2Y16.02%
EPS Next 3Y13.72%
BIT:1LXS (9/29/2025, 7:00:00 PM)
21.72
-4.86 (-18.28%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners57.91%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.88B
Analysts66.92
Price Target28.09 (29.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-6.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)265.73%
Min EPS beat(2)179.44%
Max EPS beat(2)352.03%
EPS beat(4)4
Avg EPS beat(4)283.37%
Min EPS beat(4)130.13%
Max EPS beat(4)471.87%
EPS beat(8)7
Avg EPS beat(8)156.69%
EPS beat(12)10
Avg EPS beat(12)114.53%
EPS beat(16)14
Avg EPS beat(16)92.1%
Revenue beat(2)0
Avg Revenue beat(2)-3.33%
Min Revenue beat(2)-4.87%
Max Revenue beat(2)-1.78%
Revenue beat(4)0
Avg Revenue beat(4)-3.41%
Min Revenue beat(4)-4.87%
Max Revenue beat(4)-1.78%
Revenue beat(8)2
Avg Revenue beat(8)-3.63%
Revenue beat(12)3
Avg Revenue beat(12)-2.66%
Revenue beat(16)3
Avg Revenue beat(16)-6.02%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.43 | ||
| Fwd PE | 10.21 | ||
| P/S | 0.29 | ||
| P/FCF | 17.53 | ||
| P/OCF | 4.33 | ||
| P/B | 0.43 | ||
| P/tB | 0.97 | ||
| EV/EBITDA | 7.16 |
EPS(TTM)1.9
EY8.75%
EPS(NY)2.13
Fwd EY9.79%
FCF(TTM)1.24
FCFY5.71%
OCF(TTM)5.01
OCFY23.09%
SpS73.65
BVpS50.47
TBVpS22.35
PEG (NY)4.47
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.12% | ||
| ROCE | 0.08% | ||
| ROIC | 0.06% | ||
| ROICexc | 0.06% | ||
| ROICexgc | 0.1% | ||
| OM | 0.09% | ||
| PM (TTM) | N/A | ||
| GM | 21.07% | ||
| FCFM | 1.68% |
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-49.79%
ROICexcg growth 5Y-39.03%
ROICexc growth 3Y-49.29%
ROICexc growth 5Y-40.18%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 28.05 | ||
| Debt/EBITDA | 4.27 | ||
| Cap/Depr | 58.11% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 0.14 | ||
| Cash Conversion | 76.37% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.76 |
F-Score5
WACC4.84%
ROIC/WACC0.01
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190.48%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%355.56%
EPS Next Y2.56%
EPS Next 2Y16.02%
EPS Next 3Y13.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.97%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-0.37%
Revenue Next Year-1.4%
Revenue Next 2Y0.81%
Revenue Next 3Y1.76%
Revenue Next 5YN/A
EBIT growth 1Y100.79%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1226.47%
EBIT Next 3Y155.37%
EBIT Next 5YN/A
FCF growth 1Y9.18%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-13.57%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%